Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU
Conditions: Antibiotic Side Effect Interventions: Diagnostic Test: Shorten antibiotics duration based on procalcitonin test levels Sponsors: Universiti Sains Malaysia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
A Study to Determine the Safety and Efficacy of NT-501 With MHFM
Conditions: Macular Telangiectasia Type 2 Interventions: Combination Product: NT-501 CNTF Implant Sponsors: Neurotech Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
Gilgamesh Announces Initiation of Phase 2a Trial of GM-1020 in Major Depressive Disorder
NEW YORK, May 1, 2024. Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for central nervous system disorders, today announced the initiation of patient dosing with... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 2, 2024 Category: Pharmaceuticals Source Type: clinical trials
Microdialysis and Jugular Bulb Glucose Profiles During Hyperglycaemic Clamping in Patients With Severe Acute Brain Injury
Conditions: Acute Brain Injury Interventions: Other: Hyperglycaemic clamp Sponsors: Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Effects of Ketone Monoesters on Brain Function
Conditions: Brain Insulin Sensitivity; Brain Vascular Function; Cerebral Blood Flow; Cognitive Performance; Appetite Control Interventions: Dietary Supplement: Ketone Monoester; Dietary Supplement: Placebo Sponsors: Maastricht University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Conditions: B-cell Acute Lymphoblastic Leukemia; Diffuse Large B-cell Lymphoma; Burkitt Lymphoma; Neuroblastoma; Ewing Sarcoma Interventions: Biological: Zilovertamab vedotin Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Conditions: Large Cell Neuroendocrine Carcinoma of the Lung Interventions: Drug: Durvalumab with etoposide and Carboplatin/Cisplatin Sponsors: Centre Leon Berard; Groupe Fran çais de Pneumo-Cancérologie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy
Conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Interventions: Drug: Tafamidis Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Scientists Discover How an Essential Nutrient Enters the Brain
May 1, 2024 -- Researchers have discovered that choline, an essential nutrient vital for brain health, is actively transported from the bloodstream into the brain by a protein. The findings may inform the development of new drugs that take advantage... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 1, 2024 Category: Pharmaceuticals Source Type: clinical trials
Investigating Brain Insulin Resistance In Alzheimer Disease With IntraNasal Insulin : A Multimodal Neuroimaging Study
Conditions: Alzheimer Disease; Mild Cognitive Impairment Interventions: Drug: Insulin; Drug: Placebo Sponsors: Erasme University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
PET Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51
Conditions: Alzheimer Disease Interventions: Drug: ASN51 Sponsors: Asceneuron S.A. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Randomised Controlled Study on the Efficacy of Long-term Drainage of Subdural Effusion After Decompressive Craniectomy
Conditions: Traumatic Brain Injury; Decompressive Craniectomy; Subdural Effusion Interventions: Procedure: Long-term Drainage; Procedure: Short-term Drainage Sponsors: RenJi Hospital; Zhujiang Hospital; Clinical Research Institute, Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Neuronal and Network Mechanisms of Electrocortical Stimulation
Conditions: Epilepsy; Brain Tumor Adult Sponsors: Northwestern University; Johns Hopkins University; University of Iowa; Indiana University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Neuroathletic Training in Stroke Rehabilitation? A Single-blind Randomized Controlled Pilot Study on the Potentials of Neuroathletic Training on Balance Ability in Stroke Outpatient Rehabilitation
Conditions: Stroke; Balance Postural Interventions: Behavioral: Neuroathletic training; Behavioral: Traditional movement therapy in outpatient rehabilitation Sponsors: German Sport University, Cologne Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
64Cu-DOTATATE-PET Imaging for Lyme Neuroborreliosis
Conditions: Borrelia Burgdorferi Neuroborreliosis Interventions: Diagnostic Test: Cu DOTATATE PET Sponsors: Rigshospitalet, Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
